Australia - English - Department of Health (Therapeutic Goods Administration)

stryker australia pty ltd - 48091 - reverse shoulder prosthesis base plate - a component of the tornier perform reversed augmented glenoid system intended to be attached to the scapula to serve as the foundation of the glenosphere. made of titanium alloy. the backside of the baseplate has a porous structure and the topside is solid. the center post of the baseplate accommodates a central screw for primary fixation and up to four peripheral screws for additional stability. the baseplate comes in different augment wedge angles to accommodate glenoid bone loss. a component of the tornier perform reversed augmented glenoid system intended for replacement of the glenoid part of the scapulohumeral joint as part of a reverse shoulder prosthesis. the system is intended to reduce pain and improve shoulder mobility, in comparison with preoperative status, in patients with a functional deltoid muscle and with a massive and non-repairable rotator cuff-tear.

Australia - English - Department of Health (Therapeutic Goods Administration)

stryker australia pty ltd - 36259 - prosthesis, internal, joint, shoulder, glenoid component - a component of the tornier perform reversed glenoid system intended to be attached to the central post of the baseplate via locking threads to provide primary fixation of the baseplate to the bone. the press-fit post is made of of titanium alloy. a component of the tornier perform reversed glenoid system intended for replacement of the glenoid part of the scapulohumeral joint as part of a reverse shoulder prosthesis. the system is intended to reduce pain and improve shoulder mobility, in comparison with preoperative status, in patients with a functional deltoid muscle and with a massive and non-repairable rotator cuff-tear.

Australia - English - Department of Health (Therapeutic Goods Administration)

stryker australia pty ltd - 48091 - reverse shoulder prosthesis base plate - a component of the toriner perform reversed system intended to be attached to the scapula to serve as the foundation of the glenosphere. the baseplate is made of a single piece of titanium alloy. the backside of the baseplate has a porous structure and the topside of the baseplate is solid. the center post of the baseplate accommodates a central screw or a press-fit post for primary fixation to the bone, and up to four peripheral screws for additional stability. a component of the tornier perform reversed glenoid system intended for replacement of the glenoid part of the scapulohumeral joint as part of a reverse shoulder prosthesis. the system is intended to reduce pain and improve shoulder mobility, in comparison with preoperative status, in patients with a functional deltoid muscle and with a massive and non-repairable rotator cuff-tear.

Australia - English - Department of Health (Therapeutic Goods Administration)

stryker australia pty ltd - 48093 - reverse shoulder prosthesis head - a hemispherical component of the tornier perform reversed glenoid system intended to be attached to the baseplate to articulate with a congruent reverse shoulder insert. the glenosphere is made of cobalt chromium alloy and contains a morse taper connection that mates with a taper on the baseplate components. it also includes assembled subcomponents that make up a captured locking screw used as secondary locking mechanism to lock the glenosphere onto the baseplate in addition to the taper. a component of the tornier perform reversed glenoid system intended for replacement of the glenoid part of the scapulohumeral joint as part of a reverse shoulder prosthesis. the system is intended to reduce pain and improve shoulder mobility, in comparison with preoperative status, in patients with a functional deltoid muscle and with a massive and non-repairable rotator cuff-tear.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amitriptyline hydrochloride, quantity: 50 mg - tablet - excipient ingredients: lactose monohydrate; microcrystalline cellulose; maize starch; croscarmellose sodium; colloidal anhydrous silica; purified talc; magnesium stearate; macrogol 6000; hypromellose; titanium dioxide; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - for the treatment of major depression. entrip 50mg tablets are indicated only for the maintenance treatment of major depression (see precautions). nocturnal enuresis where organic pathology has been excluded.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amitriptyline hydrochloride, quantity: 25 mg - tablet - excipient ingredients: lactose monohydrate; microcrystalline cellulose; maize starch; croscarmellose sodium; colloidal anhydrous silica; purified talc; magnesium stearate; macrogol 6000; hypromellose; titanium dioxide; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - for the treatment of major depression. nocturnal enuresis where organic pathology has been excluded.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amitriptyline hydrochloride, quantity: 10 mg - tablet - excipient ingredients: lactose monohydrate; microcrystalline cellulose; maize starch; croscarmellose sodium; colloidal anhydrous silica; purified talc; magnesium stearate; macrogol 6000; hypromellose; titanium dioxide; brilliant blue fcf aluminium lake; polyvinyl alcohol; macrogol 3350 - for the treatment of major depression. nocturnal enuresis where organic pathology has been excluded.

Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - nortriptyline hydrochloride, quantity: 11.4 mg (equivalent: nortriptyline, qty 10 mg) - tablet, uncoated - excipient ingredients: lactose monohydrate; magnesium stearate; maize starch - treatment of major depression

Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - nortriptyline hydrochloride, quantity: 28.5 mg (equivalent: nortriptyline, qty 25 mg) - tablet, uncoated - excipient ingredients: maize starch; lactose monohydrate; magnesium stearate - treatment of major depression

Australia - English - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - amitriptyline hydrochloride, quantity: 50 mg - tablet - excipient ingredients: crospovidone; maize starch; lactose monohydrate; microcrystalline cellulose; purified talc; macrogol 6000; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; sunset yellow fcf aluminium lake; indigo carmine aluminium lake - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.